Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 31/10/2013 → 30/04/2016 |
Collaborative partners
- King's College London (lead)
- Imperial College London
- AstraZeneca UK Ltd
Funding
- MRC Medical Research Council: £120,922.00
MICA: SRC inhibitors as potential antipsychotics: human testing with psilocybin
- Mehta, Mitul (Primary Investigator)
- Zelaya, Fernando (Co-Investigator)
Project: Research